DASS-21

The Depression Anxiety Stress Scales — 21 Item Version (DASS-21) is a shortened form of the original 42-item DASS, designed to measure three related negative emotional states: depression, anxiety, and stress. Developed by Professors Syd H. Lovibond and Peter F. Lovibond, the DASS-21 has become one of the most widely used mental health screening instruments worldwide.

Each item is scored from 0 ("Did not apply to me at all") to 3 ("Applied to me very much or most of the time"), with seven items per subscale. Because the DASS-21 is a shortened version of the DASS-42, individual subscale scores are multiplied by 2 to allow comparison with the full DASS normative data. This yields subscale scores ranging from 0 to 42 for each of the three dimensions.

The DASS was originally developed by Lovibond and Lovibond through extensive factor analytic research aimed at clearly differentiating depression from anxiety at the item level. Published in 1995, the work drew on large non-clinical and clinical samples to identify three distinct but correlated factors.

The Depression subscale emphasises dysphoria, hopelessness, devaluation of life, self-deprecation, lack of interest or involvement, anhedonia, and inertia. The Anxiety subscale focuses on autonomic arousal, skeletal muscle effects, situational anxiety, and subjective experience of anxious affect. The Stress subscale captures difficulty relaxing, nervous arousal, irritability and agitation, and impatience.

The DASS-21 was derived by selecting the seven highest-loading items from each of the three 14-item DASS-42 subscales. Validation studies have demonstrated that the DASS-21 maintains the three-factor structure of the full version, with good to excellent internal consistency (Cronbach's alphas typically ranging from 0.82 to 0.93 across subscales) and strong convergent and discriminant validity.

The DASS-21 uses a four-point severity/frequency scale for each item, covering the past week:

0 = Did not apply to me at all 1 = Applied to me to some degree, or some of the time 2 = Applied to me to a considerable degree or a good part of the time 3 = Applied to me very much or most of the time

Each subscale contains 7 items. Raw subscale scores (0-21) are multiplied by 2 to produce final subscale scores (0-42) comparable to the full DASS-42.

Published severity labels for the multiplied subscale scores are:

Depression: Normal (0-9), Mild (10-13), Moderate (14-20), Severe (21-27), Extremely Severe (28+) Anxiety: Normal (0-7), Mild (8-9), Moderate (10-14), Severe (15-19), Extremely Severe (20+) Stress: Normal (0-14), Mild (15-18), Moderate (19-25), Severe (26-33), Extremely Severe (34+)

These severity labels are based on normative data from large non-clinical samples and are intended to guide clinical interpretation by qualified practitioners.

The DASS-21 is used for screening, severity assessment, and outcome monitoring across mental health settings. Its three-subscale structure provides a differentiated profile of depression, anxiety, and stress, which can support clinical formulation and care planning.

The instrument's brevity (typically completed in 5 to 10 minutes) and its coverage of three core dimensions make it an efficient choice for routine clinical use. It is commonly used at intake, at regular intervals during care, and at discharge to document changes.

The DASS-21 is particularly valued for its clear separation of depressive and anxious features, which can be difficult to distinguish using single-construct measures. The Stress subscale captures a dimension of chronic non-specific arousal and tension that is not well-covered by traditional anxiety measures.

Research and clinical guidelines recommend that DASS-21 scores be interpreted by qualified practitioners as part of a comprehensive clinical assessment. The instrument is a severity measure, not a diagnostic tool.

The DASS was developed in Australia and has a particularly strong presence in Australian clinical practice. It is widely used by psychologists, GPs, psychiatrists, counsellors, and social workers across Australia.

The DASS-21 is referenced in clinical guidelines and is commonly used in Australian primary care, private practice, hospital, and community mental health settings. Australian normative data are available, supporting locally relevant interpretation of scores.

Under the DASS licensing terms, scores from the DASS instruments are intended to be provided to respondents only through a qualified practitioner, not shown directly to the respondent during unsupervised completion. This reflects the developers' position that score interpretation requires professional context.

The instrument's Australian origin and extensive local validation make it a natural choice for Australian practitioners seeking an evidence-based measure of depression, anxiety, and stress.